There were 1,950 press releases posted in the last 24 hours and 443,044 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Mesoblast Files for Orphan Drug and Pediatric Rare Disease Designations for Rexlemestrocel-L as Treatment for Severe Congenital Heart Disease

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image